Huntsman CORP
Huntsman Corporation manufactures and sells commodity and specialty chemicals, generating revenue through its global production and distribution network.
Business. Huntsman CORP (NYSE: HUN) is a diversified chemicals company operating within the Basic Materials sector. The firm generates revenue through the sale of chemical products. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on the New York Stock Exchange under the ticker symbol HUN.
Analyst recommendations
14 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Huntsman CORP (NYSE: HUN) is a diversified chemicals company operating within the Basic Materials sector. The firm generates revenue through the sale of chemical products. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on the New York Stock Exchange under the ticker symbol HUN.
Huntsman Corporation maintains a capital structure characterized by significant leverage, with total debt of $2.06 billion against $2.68 billion in total equity, resulting in a debt-to-equity ratio of 0.77. The company holds $369 million in cash and equivalents, which is insufficient to cover total debt, leading to a negative net cash position. Liquidity is assessed as medium, supported by a current ratio of 1.27, indicating adequate short-term asset coverage for liabilities. The market capitalization stands at $1.98 billion, with a price-to-book ratio of 1.0, suggesting the market values the company at its tangible book value.
Profitability metrics reflect a challenging operating environment, with the company reporting a net loss of $53 million and an operating loss of $16 million for the latest period. Return on equity is negative at -10.59%, and return on assets is -3.98%, indicating an inability to generate positive returns on invested capital. The gross profit of $183 million on $1.42 billion in revenue yields a gross margin of approximately 12.9%, which is pressured by input costs and competitive dynamics in the chemical sector. The negative free cash flow of $91 million, driven by an operating cash flow deficit of $53 million and $38 million in capital expenditures, highlights the strain on internal cash generation.
- The company reports a net loss of $53 million and negative free cash flow of $91 million, indicating significant profitability challenges.
- Debt-to-equity ratio of 0.77 and negative net cash position highlight leverage risks and the need for careful liquidity management.
- Analyst price targets suggest a potential upside, with a mean target of $15.00 compared to the current price of $11.43.
- Low dilution risk is a positive factor, suggesting no immediate pressure from share issuance.
- Upcoming earnings release on July 30, 2026, will be a key event for assessing future performance and guidance.
- Lack of historical data limits the ability to assess growth trends and long-term profitability improvements.
Bull / Bear case
Generated · model-assistedHuntsman generated $116 million in free cash flow during FY2024, demonstrating positive cash generation capabilities despite operating losses.
The company reduced long-term debt to $1.51 billion in one FY2024 period, indicating active balance sheet deleveraging efforts.
Net income surged 153.4% year-over-year in the latest FY2024 period, showing significant bottom-line improvement potential.
Operating income increased by 436.0% year-over-year in the latest FY2024 period, highlighting strong operational leverage recovery.
Huntsman faces high credit risk according to internal risk flags, signaling potential difficulties in meeting financial obligations.
The company reported a net loss of $284 million in FY2024, reflecting severe profitability challenges and negative net margins.
The net debt to EBITDA ratio stands at 10.14, indicating high leverage and limited financial flexibility.
In focus — financials by report
Revenue $1.42B; Operating income -$16.0M.
- ▍Revenue $1.42B
- ▍Operating income -$16.0M
- ▍Net margin -3.7%
Revenue $4.33B; Operating income -$72.0M.
- ▍Revenue $4.33B
- ▍Operating income -$72.0M
- ▍Net margin -4.3%
Revenue $2.87B; Operating income -$78.0M.
- ▍Revenue $2.87B
- ▍Operating income -$78.0M
- ▍Net margin -5.7%
Revenue $5.68B; Operating income -$131.0M.
- ▍Revenue $5.68B
- ▍Operating income -$131.0M
- ▍Net margin -5.0%
Revenue $6.04B; Operating income -$25.0M.
- ▍Revenue $6.04B
- ▍Operating income -$25.0M
- ▍Net margin -3.1%
Revenue $6.11B; Operating income $84.0M.
- ▍Revenue $6.11B
- ▍Operating income $84.0M
- ▍Net margin 1.7%
Revenue $6.11B; Operating income $84.0M.
- ▍Revenue $6.11B
- ▍Operating income $84.0M
- ▍Net margin 1.7%
Revenue $8.02B; Operating income $672.0M.
- ▍Revenue $8.02B
- ▍Operating income $672.0M
- ▍Net margin 5.7%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Division President · Phantom Stock → Common StockDisposed 1 513exercise · 2026-02-13
- Division President · Phantom Stock → Common StockDisposed 1 950exercise · 2026-02-13
- Division President · Phantom Stock → Common StockDisposed 3 141exercise · 2026-02-13
- Director · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
- Director · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
- Director · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
- Director · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
- Director · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
- Director, Chairman, President & CEO · Option (Right to Buy) → Common StockDisposed 241 496 @ $8,86exercise · 2026-02-03
- Division President · Option (right to buy) → Common StockDisposed 27 211 @ $8,86exercise · 2025-12-02
Actions
Ask Handelsavisen
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
- Huntsman CORP company facts · 2026-07-29
- Huntsman CORP 10-Q 2026-05-01 · 2026-07-29
- Huntsman CORP 10-K 2026-02-18 · 2026-07-29
- Huntsman CORP 10-Q 2025-11-07 · 2026-07-29
- Huntsman CORP 10-Q 2025-08-01 · 2026-07-29
- allocator_boost (allocator) on HUN · 2026-07-29
- Huntsman Corp Market data — analyst estimates · 2026-07-29
- Huntsman Corp Market data — ESG · 2026-07-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,07 %$151M
- Investment Managers · as of 2026-03-310,03 %$57M
- Investment Managers · as of 2026-03-310,02 %$93M
- Funds · as of 2026-03-310,01 %$80M
- Investment Managers · as of 2026-03-310,01 %$0M
- Investment Managers · as of 2026-03-310,01 %$64M
- Investment Managers · as of 2026-03-310,01 %$14M
- Investment Managers · as of 2024-06-300,01 %$325M
- Institutional Investor · as of 2022-09-300,01 %$0M
- Investment Managers · as of 2026-03-310,01 %$9M
- Investment Managers · as of 2026-03-310,01 %$45M
- Investment Managers · as of 2026-03-310,00 %$31M
- Investment Managers · as of 2026-03-310,00 %$25M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$62M
- Investment Managers · as of 2024-12-310,00 %$12M
- Investment Managers · as of 2025-12-310,00 %$179M
- Investment Managers · as of 2026-03-310,00 %$38M
- Investment Managers · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2026-03-310,00 %$14M
- Investment Managers · as of 2026-03-310,00 %$49M
- Institutional Investor · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$4M
- Brokerage Firms · as of 2026-03-310,00 %$6M
- Brokerage Firms · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- Director, Chairman, President & CEO · Common StockBought 100 000 @ $9,81$981K · 2026-08-03
- Division President · Common StockOther 422 @ $9,76$4K · 2026-07-31
- Division President · Common StockOther 883 @ $14,99$13K · 2026-06-02
- Exec VP & CFO · Common StockOther 3 706 @ $13,21$49K · 2026-02-13
- Sr. VP, Human Resources · Common StockOther 1 417 @ $13,21$19K · 2026-02-13
- Sr. VP, EHS · Common StockOther 630 @ $13,21$8K · 2026-02-13
- Sr. VP, EHS · Common StockOther 909 @ $13,21$12K · 2026-02-13
- Sr. VP, EHS · Common StockOther 1 281 @ $13,21$17K · 2026-02-13
- VP & Controller · Common StockOther 321 @ $13,21$4K · 2026-02-13
- VP & Controller · Common StockOther 414 @ $13,21$5K · 2026-02-13
- VP & Controller · Common StockOther 583 @ $13,21$8K · 2026-02-13
- Director, Chairman, President & CEO · Common StockOther 16 804 @ $13,21$222K · 2026-02-13
- Director, Chairman, President & CEO · Common StockOther 21 662 @ $13,21$286K · 2026-02-13
- Director, Chairman, President & CEO · Common StockOther 19 184 @ $13,21$253K · 2026-02-13
- Sr. VP, Human Resources · Common StockOther 2 329 @ $13,21$31K · 2026-02-13
- Division President · Common StockOther 1 513 · 2026-02-13
- Division President · Common StockOther 449 @ $13,21$6K · 2026-02-13
- Division President · Common StockOther 1 950 · 2026-02-13
- Division President · Common StockOther 579 @ $13,21$8K · 2026-02-13
- Division President · Common StockOther 3 141 · 2026-02-13
- Division President · Common StockOther 932 @ $13,21$12K · 2026-02-13
- Sr. VP, Human Resources · Common StockOther 1 109 @ $13,21$15K · 2026-02-13
- Division President · Common StockOther 321 @ $13,21$4K · 2026-02-13
- Division President · Common StockOther 414 @ $13,21$5K · 2026-02-13
- Division President · Common StockOther 1 514 @ $13,21$20K · 2026-02-13
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 26.2%Derived (calculated)
- Net margin (FY 2025-12-31): -5.0%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -4.6%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.30xDerived (calculated)
- Return on assets (FY 2025-12-31): -4.0%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -50.0%Derived (calculated)
- Return on equity (FY 2025-12-31): -10.3%Derived (calculated)
- Gross margin (FY 2025-12-31): 13.2%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 1.48xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -6.0%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -13.3%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 9.6%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -50.3%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -50.0%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 2.7%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -0.8%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 9.9%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -424.0%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): -5.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -7.1%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -1.4%Derived (calculated)
- Operating cash flow (annual): USD 289MSEC XBRL filing
- Capex (annual): USD 173MSEC XBRL filing
- Shareholders' equity (annual): USD 2.75BSEC XBRL filing